Home » Topics » Regulatory

Regulatory
RSS

FDA approves Somaxon's Silenor for treatment of insomnia

March 19, 2010

FDA approves 5-day dosing of Eisai's Dacogen for MDS

March 15, 2010

FDA approves Watson Pharmaceuticals' twice-yearly Trelstar formulation for prostate cancer

March 15, 2010

FDA approves Botox for upper limb spasticity in adults

March 11, 2010

FDA approves CSL Behring's Hizentra immunoglobulin therapy

March 8, 2010

FDA grants marketing approval for Shire's VPRIV for type 1 GD

March 1, 2010

FDA approves Novartis' Menveo vaccine for meningococcal disease

Feb. 22, 2010

FDA grants approval to Daiichi's hypertension treatment Benicar in pediatric patients

Feb. 12, 2010

FDA approves Xiaflex for debilitating hand disease

Feb. 4, 2010

FDA grants marketing approval to Acorda's Ampyra to improve walking in MS patients

Jan. 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.